Xcode Life Sciences

What Xcode Life Sciences does

Xcode Life Sciences is a Chennai, India-based direct-to-consumer personal genomics company founded in 2010 that provides DNA testing services to health-conscious consumers. The company's product portfolio encompasses ancestry testing, health risk assessment, paternity testing, and molecular genetic tests, with pricing spanning approximately $30 for basic services to over $2,000 for comprehensive genetic sequencing. Xcode translates raw genetic data into personalized nutrition, wellness, and disease prevention recommendations, operating in the nutrigenomics segment of the precision nutrition market.

The company distributes its services through a self-serve digital platform, selling genetic testing kits directly to individual consumers via xcode.in without traditional healthcare intermediary involvement. Marketing is driven primarily through educational content about DNA testing costs and options, targeting top-of-funnel consumer research. Xcode has raised approximately $420,000 across disclosed rounds from Shead Holdings and The Chennai Angels (2012, 2013), plus an undisclosed 2016 round from RoundGlass Partners. The company is co-founded by Naru Narayanan and Saleem Mohammed and operates with a 1-10 employee team, serving a horizontal consumer segment rather than enterprise clients.

Xcode operates within India's emerging genomic market, which benefits from declining sequencing costs (down 70% over five years) and a large, genetically diverse population. The nutrigenomics segment is projected to grow at 14.7% CAGR through 2036, and the broader precision nutrition market is expected to reach $22.82 billion by 2032. However, Xcode's specific scale, revenue, and recent operational momentum are not disclosed, limiting visibility into its current market position.

Name

Xcode Life Sciences

Website

https://xcode.in

Company type

Private

Founded year

2010

Headcount range

1–10 employees

Short description

Xcode Life Sciences is a Chennai-based direct-to-consumer personal genomics company founded in 2010 that sells DNA testing kits covering ancestry, health, paternity, and nutrition insights to health-conscious Indian consumers via its digital platform.

Ownership category

akta.pro rank

Product category

Personal Genomics / Genetic Testing Services

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

akta.pro secondary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

• DNA testing services
• Personal genomics
• Nutrigenomics analysis
• Ancestry genetic testing
• Preventative health genetics

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Direct-to-Consumer Genetic Testing Services: Revenue generated from selling genetic testing kits and services directly to individual consumers. The DTC genetic testing market segment is projected to grow from $2.4 billion in 2025 to $5.1 billion in 2032 with a CAGR of 11.1%, indicating sustained revenue opportunity in this model.
2. Genetic Testing Reports and Analysis: Sale of detailed genetic analysis reports and interpretation services to consumers. Pricing ranges broadly based on test type and complexity, from as low as $30 for some services to over $2000 for comprehensive genetic sequencing.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Xcode Life Sciences is a personal genomics company that sells direct-to-consumer DNA testing services, including ancestry, health, paternity, and molecular genetic tests. The company provides personalized nutrition, fitness, and health recommendations derived from customers' genetic analysis. Founded in 2010 and based in Chennai, India, it operates a small team delivering genetic insights for preventative healthcare.

Product overview

Xcode Life Sciences offers DNA testing services, including ancestry, health, paternity, and molecular genetic tests. Their product portfolio encompasses testing services with pricing ranging from approximately $30 for basic services to over $2,000 for comprehensive genetic sequencing.

Differentiator

Problem solved

Functional benefit

Products and services

• DNA Testing Services

Quantifiable outcome

• The nutrigenomics market is projected to grow at 14.7% CAGR from USD 781.9 million in 2026 to USD 3,081.5 million by 2036, indicating significant market opportunity for genetic nutrition companies
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Direct peers

• 23andMe: The original and largest pure-play DTC genetic testing company, offering ancestry, health risk, wellness, and trait reports directly to consumers globally. Closest direct competitor to Xcode's DNA kit + report model; competes for the same health-conscious consumers though at much larger scale and brand reach.
• AncestryDNA (Ancestry): Leading DTC genetic testing brand bundled with a genealogy platform, offering autosomal DNA testing plus ancestry reports. Directly comparable to Xcode's ancestry testing product with a similar kit-based DTC delivery model and report-driven consumer experience.
• Mapmygenome: India-based genomics company offering personal genome, wellness, and pharmacogenomics tests directly to consumers and clinicians. Headquartered in Hyderabad, India, it is the closest Indian DTC + clinical-genomics peer with overlapping product breadth (health, nutrition, traits).
• MedGenome: India-based genetic diagnostics and genomics company offering carrier screening, NIPT, and inherited disease panels across B2B clinical channels plus some DTC products. Directly comparable as a peer Indian genomic diagnostics lab with overlapping testing capabilities and report interpretation.
• MyHeritage DNA: DTC genetic testing service bundled with MyHeritage's genealogy platform, offering ancestry and ethnicity reports with a global consumer base. Comparable to Xcode's ancestry testing product line via the same DTC kit-and-report consumer flow.
• DNAfit (by Peak Wellness): DNA-based fitness and nutrition company offering genetic tests that produce personalized diet and workout guidance - effectively the nutrigenomics niche peer. Highly comparable to Xcode's personalized nutrition / wellness DNA offerings and similar DTC go-to-market.
• Helix: DTC and partner-enabled genetic testing platform offering health, wellness, and ancestry products through a marketplace model. Comparable through its DNA-kit-driven consumer insights product and lab-as-a-service orientation to Xcode's reporting-driven genetic testing model.

Emerging players

• Viome: Personalized nutrition company combining gut microbiome, transcriptome, and genetic analysis to deliver tailored food and supplement recommendations. Adjacent in the nutrigenomics/personalized nutrition category overlapping with Xcode's nutrition recommendations via DNA-based insight.

Broad incumbents

• GeneDx (Sema4): Clinical genetic testing laboratory offering exome, genome, and panels for rare disease and pediatric diagnostics to clinicians and hospitals. Broad incumbent in genetic testing whose capabilities (clinical-grade sequencing + interpretation) overlap with the underlying lab infrastructure Xcode relies on.

Others

• Genentech / Roche Genomics partners: Large incumbent pharma/genomics ecosystem with diagnostics partnerships and population genomics programs. Relevant as a benchmark for scale and as an eventual acquisition/partner counterpart for India-rooted nutrigenomics players seeking scale distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/xcode_ls
• Facebookfacebook.com/xcode.life
• LinkedInlinkedin.com/company/xcode-life-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xcode Life Sciences